SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-043107
Filing Date
2023-11-30
Accepted
2023-11-29 18:12:28
Documents
15
Period of Report
2023-11-22
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 46769
2 PRESS RELEASE DATED NOVEMBER 29, 2023 ex99-1.htm EX-99.1 13813
3 ex99-1_001.jpg GRAPHIC 8412
  Complete submission text file 0001493152-23-043107.txt   296191

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ocea-20231122.xsd EX-101.SCH 3509
5 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ocea-20231122_def.xml EX-101.DEF 26524
6 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ocea-20231122_lab.xml EX-101.LAB 36433
7 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ocea-20231122_pre.xml EX-101.PRE 25148
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5097
Mailing Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022
Business Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022 (646) 908-2658
Ocean Biomedical, Inc. (Filer) CIK: 0001869974 (see all company filings)

IRS No.: 871309280 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40793 | Film No.: 231453566
SIC: 2834 Pharmaceutical Preparations